High-throughput drug screens for amyotrophic lateral sclerosis drug discovery

McGown, A. orcid.org/0000-0002-3213-1895 and Stopford, M.J. orcid.org/0000-0002-1298-4102 (2018) High-throughput drug screens for amyotrophic lateral sclerosis drug discovery. Expert Opinion on Drug Discovery. ISSN 1746-0441

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Taylor & Francis. This is an author produced version of a paper subsequently published in Expert Opinion on Drug Discovery. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Amyotrophic lateral sclerosis (ALS); drug discovery; high-throughput drug screening (HTDS)
Dates:
  • Published (online): 13 October 2018
  • Accepted: 5 October 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 18 Oct 2018 15:02
Last Modified: 13 Oct 2019 00:38
Published Version: https://doi.org/10.1080/17460441.2018.1533953
Status: Published online
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/17460441.2018.1533953
Related URLs:

Share / Export

Statistics